Pharming Group N.V. Form 6-K Summary
Reporting period: Form 6-K filed December 22, 2020, for the month of December 2020. Pharming Group N.V. is a foreign private issuer that files annual reports on Form 20-F.
Business Context and Corporate Actions
- The filing contains two company press releases concerning the company’s Nasdaq listing structure.
- Pharming announced that its American Depositary Shares (ADSs) were admitted to trading on Nasdaq under the symbol PHAR.
- The company also announced instructions for exchanging listed ordinary shares into Nasdaq-listed ADSs.
Financial Metrics and Liquidity
The filing text does not provide financial statements, revenue, profit, cash flow, margins, debt, liquidity, guidance, or other operating metrics.
Material Changes and Outlook
The principal disclosed change is the admission of Pharming’s ADSs to trading on Nasdaq and the related process for exchanging listed ordinary shares into ADSs. The filing text does not provide management commentary, financial outlook, risk updates, contingencies, or unusual financial items.
Important Facts to Verify
- Nasdaq trading symbol: PHAR.
- Effective timing and detailed terms of the ADS admission and ordinary-share exchange process.
- The ADS-to-ordinary-share ratio, applicable fees, deadlines, and settlement procedures, which are not included in the filing text provided.
- Any subsequent financial or operating disclosures in Pharming’s Form 20-F or later filings.